Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNRX Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

NRX Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Jan 27, 2026Casper Joseph MichaelChief Operating Officer100,000Stock Option (right to buy)$217KGrant / award
Apr 9, 2025Flynn Patrick JohnDirector50,000Stock Option (right to buy)$89.5KGrant / award
Apr 9, 2025Hurvitz ChaimDirector25,000Stock Option (right to buy)$44.8KGrant / award
Apr 9, 2025McBride DennisDirector25,000Stock Option (right to buy)$44.8KGrant / award
Apr 9, 2025Javitt Jonathan CChairman and Chief Scientist125,000Stock Option (right to buy)$223.8KGrant / award
Feb 7, 2025ABRAMS MICHAEL SChief Financial Officer50,000Stock Option (right to buy)$147KGrant / award
Dec 17, 2024Javitt Jonathan CChairman and Chief Scientist40,000Common Stock$48KBuy
Aug 30, 2023Hurvitz ChaimDirector70,000Common Stock, par value $0.001 per share$224KBuy
Aug 30, 2023Gorovitz AaronDirector35,000Common Stock, par value $0.001 per share$112KBuy
Aug 23, 2023Javitt Jonathan CChief Scientist100,000Common Stock$325KBuy
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$3.32Close · Sep 22, 2026